Key result
Early identification of high-risk patients and prevention by mitigating risk factors remains the mainstay of management for cardiac surgery-associated acute kidney injury, as specific treatments lack strong evidence.
Design
Review
Authors
Loading...
Prioritizes prevention in cardiac surgery patients now; leaves open rigorous trials of targeted CSA-AKI therapies.
Early identification of high-risk patients and prevention by mitigating risk factors or avoiding renal insults remains the mainstay of management for cardiac surgery-associated acute kidney injury.
Eun‐Ho Lee (2016) conducted a review in Cardiac surgery-associated acute kidney injury (CSA-AKI). Early identification of high-risk patients and prevention by mitigating risk factors remains the mainstay of management for cardiac surgery-associated acute kidney injury, as specific treatments lack strong evidence.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: